The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Government NewsFull Access

What the Law Says

Published Online:https://doi.org/10.1176/pn.40.3.00400050

Medicaid programs have long had the authority to exclude specific classes of drugs from coverage, including benzodiazepines. Yet 41 of the 50 states cover benzodiazepine prescriptions through Medicaid or another state drug program. The Medicare Prescription Drug Improvement and Modernization Act of 2003 goes one step further, making the exclusion mandatory.

These are the nine categories of medications that may be excluded under Medicaid and must be excluded from coverage under Medicare Part D:

Agents used for anorexia, weight loss, or weight gain

Agents used to promote fertility

Agents used for cosmetic purposes or hair growth

Agents used for the symptomatic relief of cough and colds

Prescription vitamins and mineral products, except prenatal vitamins and fluoride preparations

Nonprescription drugs

Outpatient drugs for which the manufacturer seeks to require that associated tests or monitoring services be purchased exclusively from the manufacturer or its designee as a condition of sale

Barbiturates

Benzodiazepines